---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-002359"
form_type: "8-K"
ticker: "SXTP"
cik: "0001946563"
company_name: "60 DEGREES PHARMACEUTICALS, INC."
filed_at: "2026-01-08T23:59:59+00:00"
generated_at: "2026-05-16T11:15:35.485527+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# 60 Degrees Pharmaceuticals provides investor presentation via RedChip webinar; no specific details disclosed

## Summary
- Company made investor presentation available on January 8, 2026, in connection with RedChip webinar.
- Presentation covers updated clinical development timelines and regulatory strategy (no details disclosed).
- Filing includes standard forward-looking statement disclaimer; no financial guidance provided.
- Presentation exhibit (Ex. 99.1) contains only cover page and disclaimer, not slide content.

## SEC filing metadata
- accession: 0001213900-26-002359
- form_type: 8-K
- ticker: SXTP
- cik: 0001946563
- company_name: 60 DEGREES PHARMACEUTICALS, INC.
- filed_at: 2026-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1946563/000121390026002359/0001213900-26-002359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1946563/000121390026002359/ea0272213-8k_60degrees.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-002359
- JSON: https://secwatch.observer/filing/0001213900-26-002359.json
- Plain text: https://secwatch.observer/filing/0001213900-26-002359.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.